Specific binding members for NGF

Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralize NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SLEEMAN MATTHEW ALEXANDER, BUCHANAN ANDREW GRIER, THOM ALBERT GEORGE, HAWKINSON JON ERIC, WELSH FRASER EWING, FRANKS RUTH, BLAND-WARD PHILIP ANTONY, MATTHEWS CARL ANTHONY, HART CELIA PATRICIA
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SLEEMAN MATTHEW ALEXANDER
BUCHANAN ANDREW GRIER
THOM ALBERT GEORGE
HAWKINSON JON ERIC
WELSH FRASER EWING
FRANKS RUTH
BLAND-WARD PHILIP ANTONY
MATTHEWS CARL ANTHONY
HART CELIA PATRICIA
description Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralize NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9315571B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9315571B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9315571B23</originalsourceid><addsrcrecordid>eNrjZFAILkhNzkzLTFZIysxLycxLV8hNzU1KLSpWSMsvUvBzd-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGhwZbGhqam5oZORsZEKAEA1d4kZQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Specific binding members for NGF</title><source>esp@cenet</source><creator>SLEEMAN MATTHEW ALEXANDER ; BUCHANAN ANDREW GRIER ; THOM ALBERT GEORGE ; HAWKINSON JON ERIC ; WELSH FRASER EWING ; FRANKS RUTH ; BLAND-WARD PHILIP ANTONY ; MATTHEWS CARL ANTHONY ; HART CELIA PATRICIA</creator><creatorcontrib>SLEEMAN MATTHEW ALEXANDER ; BUCHANAN ANDREW GRIER ; THOM ALBERT GEORGE ; HAWKINSON JON ERIC ; WELSH FRASER EWING ; FRANKS RUTH ; BLAND-WARD PHILIP ANTONY ; MATTHEWS CARL ANTHONY ; HART CELIA PATRICIA</creatorcontrib><description>Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralize NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160419&amp;DB=EPODOC&amp;CC=US&amp;NR=9315571B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160419&amp;DB=EPODOC&amp;CC=US&amp;NR=9315571B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SLEEMAN MATTHEW ALEXANDER</creatorcontrib><creatorcontrib>BUCHANAN ANDREW GRIER</creatorcontrib><creatorcontrib>THOM ALBERT GEORGE</creatorcontrib><creatorcontrib>HAWKINSON JON ERIC</creatorcontrib><creatorcontrib>WELSH FRASER EWING</creatorcontrib><creatorcontrib>FRANKS RUTH</creatorcontrib><creatorcontrib>BLAND-WARD PHILIP ANTONY</creatorcontrib><creatorcontrib>MATTHEWS CARL ANTHONY</creatorcontrib><creatorcontrib>HART CELIA PATRICIA</creatorcontrib><title>Specific binding members for NGF</title><description>Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralize NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAILkhNzkzLTFZIysxLycxLV8hNzU1KLSpWSMsvUvBzd-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGhwZbGhqam5oZORsZEKAEA1d4kZQ</recordid><startdate>20160419</startdate><enddate>20160419</enddate><creator>SLEEMAN MATTHEW ALEXANDER</creator><creator>BUCHANAN ANDREW GRIER</creator><creator>THOM ALBERT GEORGE</creator><creator>HAWKINSON JON ERIC</creator><creator>WELSH FRASER EWING</creator><creator>FRANKS RUTH</creator><creator>BLAND-WARD PHILIP ANTONY</creator><creator>MATTHEWS CARL ANTHONY</creator><creator>HART CELIA PATRICIA</creator><scope>EVB</scope></search><sort><creationdate>20160419</creationdate><title>Specific binding members for NGF</title><author>SLEEMAN MATTHEW ALEXANDER ; BUCHANAN ANDREW GRIER ; THOM ALBERT GEORGE ; HAWKINSON JON ERIC ; WELSH FRASER EWING ; FRANKS RUTH ; BLAND-WARD PHILIP ANTONY ; MATTHEWS CARL ANTHONY ; HART CELIA PATRICIA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9315571B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SLEEMAN MATTHEW ALEXANDER</creatorcontrib><creatorcontrib>BUCHANAN ANDREW GRIER</creatorcontrib><creatorcontrib>THOM ALBERT GEORGE</creatorcontrib><creatorcontrib>HAWKINSON JON ERIC</creatorcontrib><creatorcontrib>WELSH FRASER EWING</creatorcontrib><creatorcontrib>FRANKS RUTH</creatorcontrib><creatorcontrib>BLAND-WARD PHILIP ANTONY</creatorcontrib><creatorcontrib>MATTHEWS CARL ANTHONY</creatorcontrib><creatorcontrib>HART CELIA PATRICIA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SLEEMAN MATTHEW ALEXANDER</au><au>BUCHANAN ANDREW GRIER</au><au>THOM ALBERT GEORGE</au><au>HAWKINSON JON ERIC</au><au>WELSH FRASER EWING</au><au>FRANKS RUTH</au><au>BLAND-WARD PHILIP ANTONY</au><au>MATTHEWS CARL ANTHONY</au><au>HART CELIA PATRICIA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Specific binding members for NGF</title><date>2016-04-19</date><risdate>2016</risdate><abstract>Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralize NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9315571B2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Specific binding members for NGF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T21%3A01%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SLEEMAN%20MATTHEW%20ALEXANDER&rft.date=2016-04-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9315571B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true